NMR Reporter Assays for the Quantification of Weak-Affinity Receptor-Ligand Interactions
Teresa B Almeida1, Stanislava Panova1, Reto Walser1
1Molecular Sciences, Astex Pharmaceuticals, Cambridge, UK.
SLAS Discovery : Advancing Life Sciences R & D
|April 26, 2021
Summary
Ligand-observed (LO) nuclear magnetic resonance (NMR) assays offer a valuable alternative to protein-observed (PO) NMR for quantifying weak molecular interactions in drug discovery, providing advantages in protein use and throughput.
Area of Science:
- Biophysics
- Chemical Biology
- Structural Biology
Background:
- Biophysical methods are crucial for detecting and quantifying molecular interactions in pharmaceutical research and academia.
- Fragment-based drug discovery (FBDD) relies heavily on accurate affinity determination methods.
- Protein-observed (PO) nuclear magnetic resonance (NMR) is a sensitive technique for studying weak interactions at residue-level resolution.
Purpose of the Study:
- To provide guidance on setting up ligand-observed (LO) NMR reporter assays for routine use.
- To achieve high-quality, accurate data and good throughput with LO-NMR assays.
- To compare the performance of LO-NMR assays with other common affinity determination methods in drug discovery.
Main Methods:
- Assessment of LO-NMR assay characteristics within a mathematical framework similar to fluorescence polarization assays.
- Detailed guidance on assay setup for routine application.
- Comparative analysis of LO-NMR assay performance against alternative affinity determination techniques.
Main Results:
- LO-NMR assays can measure molecular interaction affinities in a range comparable to PO-NMR.
- LO-NMR assays present distinct advantages, particularly concerning protein consumption and compound throughput.
- The study provides a framework for understanding and optimizing LO-NMR assay performance.
Conclusions:
- LO-NMR reporter assays are a viable and advantageous alternative to PO-NMR when the latter faces limitations.
- Optimization of LO-NMR assay setup is key to obtaining reliable data and efficient screening.
- These assays contribute significantly to advancing drug discovery projects, especially in FBDD.
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
14.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.4K
Quantitative Aspects of Drug-Receptor Interaction
1.5K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.5K


